News & Events

September 9, 2021

BrainsWay to Participate in Two Upcoming Investor Conferences

BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

August 30, 2021

BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, August 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

August 18, 2021

FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients

Expanded Depression Indication Further Demonstrates Company’s Leadership Position BURLINGTON, Mass....

August 17, 2021

BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorders

BURLINGTON, MA. and JERUSALEM, August 17, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

August 11, 2021

BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights

Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for...

July 28, 2021

BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021

CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

July 6, 2021

BrainsWay to Present at the Ladenburg Thalmann 2021 Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, July 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

June 8, 2021

BrainsWay to Present at the Raymond James Human Health Innovation Conference

CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 7, 2021

BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate

CRESSKILL, N.J. and JERUSALEM, Israel, June 7, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

June 2, 2021

BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC

HCSC Covers Approximately 17 Million Members Across Five States CRESSKILL, N.J. and JERUSALEM, Israel,...

June 1, 2021

BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor

Palmetto GBA, Administrator of Medicare in Seven States, Publishes Draft Local Coverage Determination CRESSKILL,...

May 24, 2021

BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™

CRESSKILL, N.J. and JERUSALEM, Israel, March 24, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

May 20, 2021

BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights

*Note, the numbers contained herein reflect certain updates to the previous unaudited financial results...

May 19, 2021

BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

May 6, 2021

BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021

CRESSKILL, N.J. and JERUSALEM, Israel, May 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

May 5, 2021

BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer

CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

May 4, 2021

BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month

The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an...

May 3, 2021

BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...